Core Insights - Madison Square Garden Entertainment (MSGE) reported revenue of $459.94 million for the quarter ended December 2025, marking a year-over-year increase of 12.9% and an EPS of $1.94 compared to $1.56 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $450.19 million by 2.17%, while the EPS fell short of the consensus estimate of $2.35 by 17.45% [1] Revenue Breakdown - Arena license fees and other leasing revenue reached $35.16 million, surpassing the estimated $30.89 million by two analysts, reflecting a year-over-year increase of 17.9% [4] - Revenues from entertainment offerings totaled $360.45 million, significantly exceeding the two-analyst average estimate of $265.91 million [4] - Food, beverage, and merchandise revenues were reported at $64.32 million, slightly below the estimated $65.41 million, but still showing an 8.4% increase compared to the previous year [4] Stock Performance - Shares of MSG Entertainment have returned +14.1% over the past month, outperforming the Zacks S&P 500 composite's +1.8% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - NewtekOne (NEWT) reported a revenue of $73.33 million for the quarter ended December 2025, reflecting a year-over-year decline of 2.7% and an EPS of $0.65, down from $0.69 a year ago [1] - The reported revenue fell short of the Zacks Consensus Estimate of $80.99 million, resulting in a surprise of -9.45% [1] - The company did not deliver an EPS surprise, as the consensus EPS estimate was also $0.65 [1] Financial Performance Metrics - NewtekOne's efficiency ratio was reported at 55.2%, which is higher than the two-analyst average estimate of 52.7% [4] - Total noninterest income was $55.85 million, below the average estimate of $62.12 million based on three analysts [4] - Net interest income stood at $17.48 million, compared to the average estimate of $18.87 million from three analysts [4] - Noninterest income from servicing was $5.2 million, slightly below the average estimate of $5.5 million based on two analysts [4] - Electronic payment processing income was reported at $10.45 million, compared to the average estimate of $12.27 million from two analysts [4] - Other noninterest income was $8.81 million, below the two-analyst average estimate of $10.73 million [4] - The net loss on loan servicing assets was reported at -$4.19 million, better than the average estimate of -$4.75 million from two analysts [4] - Dividend income was $0.5 million, slightly above the average estimate of $0.44 million based on two analysts [4] - Net gains on sales of loans were reported at $9.51 million, significantly lower than the two-analyst average estimate of $16.55 million [4] Stock Performance - Over the past month, shares of NewtekOne have returned +20.4%, outperforming the Zacks S&P 500 composite's +0.8% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Core Insights - Duke Energy reported $8.54 billion in revenue for Q3 2025, a year-over-year increase of 4.8% and a surprise of +1.48% over the Zacks Consensus Estimate of $8.42 billion [1] - The EPS for the quarter was $1.81, compared to $1.62 a year ago, with a surprise of +4.02% over the consensus estimate of $1.74 [1] Revenue Breakdown - Regulated natural gas operating revenues were $361 million, below the average estimate of $504.2 million, with a year-over-year change of +21.1% [4] - Regulated electric operating revenues reached $8.11 billion, exceeding the $7.5 billion average estimate, reflecting a +4.3% year-over-year change [4] - Nonregulated electric and other revenues were $75 million, below the estimated $82.64 million, showing a -7.4% change compared to the previous year [4] - Gas Utilities and Infrastructure revenues were $394 million, surpassing the average estimate of $357.26 million, with an +18.7% year-over-year change [4] - Electric Utilities and Infrastructure revenues were $8.18 billion, slightly above the estimated $8.12 billion, indicating a +4.2% change year-over-year [4] Stock Performance - Duke Energy's shares returned -0.6% over the past month, compared to the Zacks S&P 500 composite's -0.2% change [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance against the broader market in the near term [3]

Core Viewpoint - AMN Healthcare Services reported a decline in revenue and earnings for the quarter ended September 2025, with a notable surprise in EPS performance compared to analyst expectations [1][3]. Financial Performance - Revenue for the quarter was $634.5 million, down 7.7% year-over-year, but exceeded the Zacks Consensus Estimate of $615.14 million by 3.15% [1]. - Earnings per share (EPS) was $0.39, a decrease from $0.61 in the same quarter last year, but significantly higher than the consensus estimate of $0.19, resulting in an EPS surprise of 105.26% [1]. Segment Performance - Physician and leadership solutions reported revenue of $178.21 million, slightly above the average estimate of $175.12 million, but down 1.3% year-over-year [4]. - Nurse and allied solutions generated $361.48 million in revenue, surpassing the estimated $346.66 million, but reflecting a 9.5% decline compared to the previous year [4]. - Technology and workforce solutions achieved $94.81 million in revenue, exceeding the average estimate of $93.42 million, with an 11.8% year-over-year decrease [4]. Operating Income - Segment operating income for nurse and allied solutions was $28.76 million, above the estimated $24.57 million [4]. - Operating income for technology and workforce solutions was $30.89 million, below the average estimate of $33.09 million [4]. - Physician and leadership solutions had an operating income of $15.73 million, slightly above the estimated $15.37 million [4]. Stock Performance - AMN Healthcare shares returned 7.1% over the past month, outperforming the Zacks S&P 500 composite, which saw a 1.3% change [3]. - The stock currently holds a Zacks Rank of 5 (Strong Sell), indicating potential underperformance in the near term [3].

Core Insights - GoodRx Holdings, Inc. reported revenue of $196.03 million for the quarter ended September 2025, reflecting a year-over-year increase of 0.4% [1] - The earnings per share (EPS) for the same period was $0.08, unchanged from the previous year, but below the consensus estimate of $0.09, resulting in an EPS surprise of -11.11% [1] - The reported revenue exceeded the Zacks Consensus Estimate of $193.43 million, indicating a positive surprise of +1.34% [1] Financial Performance Metrics - Monthly Active Consumers stood at 5, matching the average estimate from three analysts [4] - Subscription plans reached 671, slightly above the average estimate of 662 from two analysts [4] - Revenue from prescription transactions was $127.29 million, below the average estimate of $131.26 million, representing a year-over-year decline of -9.3% [4] - Revenue from other sources was $4.64 million, slightly above the estimated $4.5 million, but down -14% compared to the previous year [4] - Revenue from pharmaceutical manufacturer solutions was $43.37 million, exceeding the average estimate of $37.06 million, marking a significant year-over-year increase of +54.4% [4] - Subscription revenue was reported at $20.72 million, slightly above the estimate of $20.26 million, but down -2.7% year-over-year [4] Stock Performance - GoodRx shares have declined by -27.7% over the past month, contrasting with a +2.1% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Insights - Kratos (KTOS) reported $347.6 million in revenue for Q3 2025, a 26% year-over-year increase, with an EPS of $0.14 compared to $0.11 a year ago, exceeding both revenue and EPS estimates [1][4] Revenue Breakdown - Product sales reached $230.2 million, surpassing the average estimate of $191.59 million, reflecting a 33.8% year-over-year increase [4] - Unmanned Systems generated $87.2 million, exceeding the estimated $77.18 million, marking a 35.8% increase from the previous year [4] - Kratos Government Solutions reported $260.4 million, above the $248.03 million estimate, representing a 23% year-over-year growth [4] - Service revenues totaled $117.4 million, below the average estimate of $133.04 million, with a 13% increase year-over-year [4] Profitability Metrics - Gross profit from service revenues was $26.2 million, lower than the $33.11 million estimate [4] - Gross profit from product sales was $50.9 million, exceeding the $44.6 million estimate [4] - Operating income for Kratos Government Solutions was $13.7 million, below the $16.75 million estimate [4] Stock Performance - Kratos shares have returned -9.1% over the past month, contrasting with the Zacks S&P 500 composite's +2.1% change, but the stock holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

Core Insights - Advanced Micro Devices (AMD) reported a revenue of $9.25 billion for the quarter ended September 2025, reflecting a year-over-year increase of 35.6% and surpassing the Zacks Consensus Estimate by 6% [1] - Earnings per share (EPS) for the quarter was $1.20, up from $0.92 in the same quarter last year, with an EPS surprise of 2.56% over the consensus estimate of $1.17 [1] Revenue Breakdown - Data Center revenue reached $4.34 billion, exceeding the average estimate of $4.18 billion by analysts, marking a year-over-year increase of 22.3% [4] - Embedded revenue was reported at $857 million, falling short of the average estimate of $903.49 million, representing a decline of 7.6% year over year [4] - Gaming revenue surged to $1.3 billion, significantly surpassing the average estimate of $1.05 billion, with a remarkable year-over-year growth of 181% [4] - Client revenue amounted to $2.75 billion, exceeding the average estimate of $2.6 billion, reflecting a year-over-year increase of 46.2% [4] Stock Performance - AMD shares have returned 27.5% over the past month, outperforming the Zacks S&P 500 composite, which saw a change of 2.1% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - Neurocrine Biosciences reported revenue of $794.9 million for the quarter ended September 2025, reflecting a year-over-year increase of 27.8% and surpassing the Zacks Consensus Estimate by 6.73% [1] - The company's EPS for the quarter was $2.04, up from $1.24 in the same quarter last year, resulting in an EPS surprise of 29.11% compared to the consensus estimate of $1.58 [1] Revenue Breakdown - Product sales from INGREZZA reached $686.6 million, exceeding the average estimate of $664.3 million, marking a 12% year-over-year increase [4] - Total product sales amounted to $789.9 million, surpassing the nine-analyst average estimate of $736.39 million, with a year-over-year change of 28.1% [4] - CRENESSITY generated $98.1 million in product sales, exceeding the average estimate of $67.22 million [4] - Collaboration revenue was reported at $5 million, slightly below the estimated $5.69 million, representing a decline of 9.1% year-over-year [4] - Royalty collaboration revenue was $4.8 million, compared to the average estimate of $5.1 million [4] - Other product sales reached $5.2 million, exceeding the average estimate of $4.25 million [4] Stock Performance - Neurocrine's shares have returned 6.2% over the past month, outperforming the Zacks S&P 500 composite's 3.6% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - Carter Bankshares, Inc. reported revenue of $39.25 million for the quarter ended September 2025, marking a year-over-year increase of 14.1% [1] - The earnings per share (EPS) for the same period was $0.26, compared to $0.23 a year ago [1] - The reported revenue fell short of the Zacks Consensus Estimate of $39.8 million, resulting in a surprise of -1.38% [1] - The company experienced an EPS surprise of -33.33%, with the consensus EPS estimate being $0.39 [1] Financial Metrics - The efficiency ratio was reported at 73.4%, which is higher than the two-analyst average estimate of 72% [4] - The net interest margin stood at 2.9%, aligning with the average estimate based on two analysts [4] - Total noninterest income was $5.37 million, slightly above the two-analyst average estimate of $5.35 million [4] Stock Performance - Over the past month, shares of Carter Bankshares have returned -3.5%, contrasting with the Zacks S&P 500 composite's +0.2% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - Opera Limited reported $142.96 million in revenue for the quarter ended June 2025, marking a year-over-year increase of 30.3% [1] - The earnings per share (EPS) for the same period was $0.26, compared to $0.22 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $137.81 million by 3.74%, while the EPS fell short of the consensus estimate of $0.27 by 3.7% [1] Revenue Breakdown - Revenue from Search was $44.55 million, below the estimated $47.97 million [4] - Revenue from Advertising was $64.63 million, significantly lower than the estimated $88.66 million [4] - Revenue from Technology licensing and other sources was $0.56 million, exceeding the estimated $0.1 million [4] Stock Performance - Over the past month, shares of Opera Limited have returned -4.1%, contrasting with the Zacks S&P 500 composite's +2.5% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]